Igene Biotechnology, Inc. (IGNE)

Market Cap	1.57K
Revenue (ttm)	4.80K -99.9%
Net Income	-2.37M
EPS	-0.00
Shares Out	1.56B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,560
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.000001 - 0.00001
Beta	-28.02
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Igene Biotechnology

Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, ...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1981
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: IGNE

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 12, 2026

Data Sources Report a data error